Understanding Integrating New Options Into The Sclc Treatment Arsenal To Improve Patient Outcomes
Exploring Integrating New Options Into The Sclc Treatment Arsenal To Improve Patient Outcomes reveals several interesting facts. Chair, Jacob Sands, MD, discusses
Key Takeaways about Integrating New Options Into The Sclc Treatment Arsenal To Improve Patient Outcomes
- Join Drs Sands, Leal, and Shields for a live CME-certified social media event featuring dynamic discussion on managing ...
- Stephen V. Liu, MD, Anna F. Farago, MD, PhD, and Leora Horn, MD, MSc, FRCPC, discuss
- Chair & Presenter, Jacob Sands, MD, Ticiana A. Leal, MD, and Jared Weiss, MD, discuss
- Stephen V. Liu, MD, Jonathan W. Goldman, MD, Kristin Higgins, MD, Joanna-Grace M. Manzano, MD, MPH, FACP, and Gerard A.
- In this video series that was recorded in November 2025, leading oncologists present
Detailed Analysis of Integrating New Options Into The Sclc Treatment Arsenal To Improve Patient Outcomes
In this video series that was recorded in November 2025, leading oncologists present Chair, Taofeek K. Owonikoko, MD, PhD, Carl M. Gay, MD, PhD, and Jacob Sands, MD, discuss Chair and Presenter, Jonathan W. Goldman, MD, Ticiana A. Leal, MD, and Taofeek K. Owonikoko, MD, PhD, discuss
Dr. Cathy Pietanza from Memorial Sloan Kettering Cancer Center discusses standard chemotherapy
Stay tuned for more updates related to Integrating New Options Into The Sclc Treatment Arsenal To Improve Patient Outcomes.
